Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,354.00
-21.20 (-1.54%)
Jul 31, 2026, 3:30 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 187.72 billion as of July 31, 2026. Its market cap has decreased by -24.13% in one year.
Market Cap
187.72B
Enterprise Value
210.56B
Revenue
32.12B
Ranking
n/a
PE Ratio
28.91
Stock Price
1,354.00
ChartMarket Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 187.72B, an increase of 126.97%. That is a compound annual growth rate of 9.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 187.72B | -8.47% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 414.69B |
| Emcure Pharmaceuticals | 371.61B |
| Wockhardt | 318.44B |
| Piramal Pharma | 259.61B |
| NATCO Pharma | 166.55B |
| Cohance Lifesciences | 162.71B |
| Alembic Pharmaceuticals | 156.67B |
| Alivus Life Sciences | 142.38B |